Trevi Therapeutics, Inc. (TRVI) Revenue History
Annual and quarterly revenue from 2016 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TRVI Revenue Growth
TRVI Revenue Analysis (2016–2025)
As of May 8, 2026, Trevi Therapeutics, Inc. (TRVI) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, TRVI's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including IDYA (+3118.1% YoY), PTCT (-53.3% YoY), and ACAD (+9.9% YoY). Compare TRVI vs IDYA →
TRVI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TRVICurrent | $0 | - | - | - | |
 IDYA | $219M | +3118.1% | +62.1% | -72.8% | |
 PTCT | $1.7B | -53.3% | +35.4% | 49.5% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% |
TRVI Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-49,328,000 | - |
| 2024 | $0 | - | $0 | - | $-51,524,000 | - |
| 2023 | $0 | - | $0 | - | $-33,923,000 | - |
| 2022 | $0 | - | $0 | - | $-29,907,000 | - |
| 2021 | $0 | - | $0 | - | $-32,476,000 | - |
| 2020 | $0 | - | $-47,000 | - | $-32,489,000 | - |
| 2019 | $0 | - | $-39,000 | - | $-26,645,000 | - |
| 2018 | $0 | - | $-23,000 | - | $-18,408,000 | - |
| 2017 | $0 | - | $0 | - | $-8,237,000 | - |
| 2016 | $0 | - | $-4,000 | - | $-8,625,000 | - |
See TRVI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TRVI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TRVI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTRVI — Frequently Asked Questions
Quick answers to the most common questions about buying TRVI stock.
Is TRVI's revenue growth accelerating or slowing?
TRVI TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TRVI's long-term revenue growth rate?
Trevi Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is TRVI's revenue distributed by segment?
TRVI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2025 are available for download. Segment mix reveals concentration and diversification trends.